ReGen therapeutics Plc Company Profile

16:38 EDT 19th September 2018 | BioPortfolio

The principal activity of ReGen Therapeutics Plc is the development and exploration of Colostrinin as a drug for the prophylaxis and treatment of Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex isolated from ovine colostrinin. Colostrum is the mammal's first milk after the birth of an offspring.


6 Chelmsford Road, South Woodford
E18 2PL
United Kingdom


Phone: 0208 504 2156
Fax: 0208 504 2156

News Articles [723 Associated News Articles listed on BioPortfolio]

Regen La's PRP, BMC and HA technologies receives US patents

Antoine Turzi, inventor, Regen Lab SA and Regen Lab USA LLC are announced that the United States Patent and Trademark Office (USPTO) has issued two new US patents covering its Platelet Rich Plasma (PR...

Regen BioPharma Reports Molecule Screening Success

Identified novel chemical compounds that appear to inhibit NR2F6 and show potential for treating autoimmune diseases

Neue US-Patente für RegenLab erteilt

LE-MONT-SUR LAUSANNE, Schweiz, September 13, 2018 /PRNewswire/ -- Herr Antoine Turzi, Erfinder, Regen Lab SA und RegenLab USA LLC freuen sich, bekannt zu geben, dass Read more...

ROUNDUP: Goldman Sachs verdient glänzend an unruhigen Finanzmärkten

Die führende US-Investmentbank Goldman Sachs hat zu Jahresbeginn vom regen Handel an den Finanzmärkten profitiert. Verglichen mit dem Vorjahreswert stieg der Überschuss um 26 Prozent auf 2,8 Milli....

Barclays belässt Sanofi auf 'Underweight' - Ziel 60 Euro

Die britische Investmentbank Barclays hat die Einstufung für Sanofi auf "Underweight" mit einem Kursziel von 60 Euro belassen. Nach einem schwachen Start zeige der Trend bei dem zusammen mit Regen...

PAIN DOCTOR Pain & Regenerative Medicine Offers New BioBurst Rejuv and Liveyon ReGen® Umbilical Cord Stem Cell Therapies and AmnioFix® Treatment to Promote Tissue Healing

On the forefront of regenerative medicine, PAIN DOCTOR Pain & Regenerative Medicine serving Arlington, Fort Worth, Dallas and surrounding Texas cities is offering new umbilical cord stem cell ther...

Regen BioPharma Inc RGBP Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryRegen BioPharma Inc Regen BioPharma, a subsidiary of BioMatrix Scientific Group Inc is a biotechnology company that concentrates on the development of immunotherapies and cancer stem cell thera...

Technical Perspectives on Biotech Stocks -- Adaptimmune Therapeutics, Akebia Therapeutics, ... Adaptimmune Therapeutics Shares in Abingdon, the UK headquartered Adaptimmune Therapeutics PLC rose slightly by 0.41%, ending Wednesday's trading session at $12...

PubMed Articles [434 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development: Preclinical Research.

Clinical Trials [155 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty

Autologous glue therapy with platelet-rich plasma (PRP) was reported to improve outcomes in plastic surgery. However, only pilot studies and retrospective uncontrolled trials have reported...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1259 Associated Companies listed on BioPortfolio]

ReGen therapeutics Plc

The principal activity of ReGen Therapeutics Plc is the development and exploration of Colostrinin as a drug for the prophylaxis and treatment of Alzheimer's disease and other neurological disorders. ...

ReGen Biologics

ReGen Biologics is an orthopedic products company that develops, manufactures and markets innovative tissue repair products for U.S. and global markets.ReGen's patented collagen scaffold technology in...

ReGen Biologics, Inc.

Ennova Direct, Inc.

Ennova Direct, Inc. ( was founded in 2003 by Paul Regen and Peter Garrett, and is located at the northern end of the Monterey Bay in Scotts Valley, CA....

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "ReGen therapeutics Plc" on BioPortfolio

We have published hundreds of ReGen therapeutics Plc news stories on BioPortfolio along with dozens of ReGen therapeutics Plc Clinical Trials and PubMed Articles about ReGen therapeutics Plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReGen therapeutics Plc Companies in our database. You can also find out about relevant ReGen therapeutics Plc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record